Literature DB >> 11545287

Does sperm morphology play a significant role in increased sex chromosomal disomy? A comparison between patients with teratozoospermia and OAT by FISH.

L A Gole1, P F Wong, P L Ng, X Q Wang, S C Ng, A Bongso.   

Abstract

Eight semen samples from men with teratozoospermia (T), along with samples from 3 men with normal fertility and 5 samples from men with oligoasthenoteratozoospermia (OAT) were analyzed for X and Y chromosomal anomalies with the use of fluorescently labeled centromeric probes. This study was undertaken to determine whether patients with abnormal sperm morphology (teratozoospermia) have increased or decreased incidence of a sex chromosomal anomaly. The sex chromosome disomy for the T samples was 0.36% and for the OAT group it was 0.61%, compared with baseline value for the normozoospermia group (0.09%).

Entities:  

Mesh:

Year:  2001        PMID: 11545287

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  4 in total

1.  Detection of DNA fragmentation and meiotic segregation in human with isolated teratozoospermia.

Authors:  Sonia Brahem; Meriem Mehdi; Hatem Elghezal; Ali Saad
Journal:  J Assist Reprod Genet       Date:  2010-09-25       Impact factor: 3.412

2.  Meiotic segregation and sperm DNA fragmentation in Tunisian men with dysplasia of the fibrous sheath (DFS) associated with head abnormalities.

Authors:  H Ghedir; A Mehri; M Mehdi; S Brahem; A Saad; S Ibala-Romdhane
Journal:  J Assist Reprod Genet       Date:  2014-07-08       Impact factor: 3.412

3.  Nuclear organisation of sperm remains remarkably unaffected in the presence of defective spermatogenesis.

Authors:  Dimitris Ioannou; Eric J Meershoek; Dimitra Christopikou; Michael Ellis; Alan R Thornhill; Darren Karl Griffin
Journal:  Chromosome Res       Date:  2011-09-27       Impact factor: 5.239

Review 4.  Is there a relationship between sperm chromosome abnormalities and sperm morphology?

Authors:  Fei Sun; Evelyn Ko; Renée H Martin
Journal:  Reprod Biol Endocrinol       Date:  2006-01-25       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.